AN ANTI-CANCER DRUG PROSPIDINE - FAILURE TO REVEAL ANTI-MITOTIC AND CLASTOGENIC ACTION ON REGENERATING MOUSE-LIVER

被引：0
|
作者：
URYVAEVA, IV [1 ]
SOKOLOVA, AS [1 ]
FAKTOR, VM [1 ]
CHERNOV, VA [1 ]
BRODSKY, WY [1 ]
机构：
[1] S ORDZHONIKIDZE PHARMACEUT CHEM RES INST,MOSCOW,USSR
来源：
NEOPLASMA | 1983年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：457 / 462
页数：6
相关论文
共 50 条
  • [21] Anti-cancer drug development using bioactive compounds from Tillandsia recurvata in mouse models of human cancer
    Lowe, Henry
    Bryant, Joseph
    Bahado-Singh, Perceval
    Morrison, Errol
    CANCER RESEARCH, 2012, 72
  • [22] Investigations on the biological properties of the lipophilic DHFR-inhibitory benzoprims reveal non-folate modes of action and opportunities for anti-cancer drug design
    Croughton, KA
    Matthews, CS
    Griffin, RJ
    Stevens, MFG
    ANTI-CANCER DRUG DESIGN, 2001, 16 (2-3): : 119 - 128
  • [23] Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin
    Xin, Hong-Wu
    Ambe, Chenwi M.
    Miller, Tyler C.
    Chen, Jin-Qiu
    Wiegand, Gordon W.
    Anderson, Andrew J.
    Ray, Satyajit
    Mullinax, John E.
    Hari, Danielle M.
    Koizumi, Tomotake
    Godbout, Jessica D.
    Goldsmith, Paul K.
    Stojadinovic, Alexander
    Rudloff, Udo
    Thorgeirsson, Snorri S.
    Avital, Itzhak
    JOURNAL OF CANCER, 2016, 7 (09): : 1142 - 1151
  • [24] Screening of different drug design tools to predict the mode of action of steroidal derivatives as anti-cancer agents
    Nafie, Mohamed S.
    Tantawy, Mohamed A.
    Elmgeed, Gamal A.
    STEROIDS, 2019, 152
  • [25] Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro, F
    Decaestecker, C
    Gaussin, JF
    Mortier, S
    Van Ginckel, R
    Kiss, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (03) : 607 - 616
  • [26] DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells
    Obara, Akio
    Fujita, Yoshihito
    Abudukadier, Abulizi
    Fukushima, Toru
    Oguri, Yasuo
    Ogura, Masahito
    Harashima, Shin-ichi
    Hosokawa, Masaya
    Inagaki, Nobuya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 460 (04) : 1047 - 1052
  • [27] A novel liver-specific fluorescent anti-cancer drug delivery system using indocyanine green
    Yoshinori Inagaki
    Takashi Kokudo
    Mako Kamiya
    Shin-nosuke Uno
    Masumitsu Sato
    Junichi Kaneko
    Norihiro Kokudo
    Yasuteru Urano
    Kiyoshi Hasegawa
    Scientific Reports, 9
  • [28] A novel liver-specific fluorescent anti-cancer drug delivery system using indocyanine green
    Inagaki, Yoshinori
    Kokudo, Takashi
    Kamiya, Mako
    Uno, Shin-nosuke
    Sato, Masumitsu
    Kaneko, Junichi
    Kokudo, Norihiro
    Urano, Yasuteru
    Hasegawa, Kiyoshi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy
    Ju, Hye-Lim
    Han, Kwang-Hyub
    Lee, Jong Doo
    Ro, Simon Weonsang
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (07) : 1601 - 1608
  • [30] Impedance spectroscopy with field-effect transistor arrays for the analysis of anti-cancer drug action on individual cells
    Susloparova, A.
    Koppenhoefer, D.
    Vu, X. T.
    Weil, M.
    Ingebrandt, S.
    BIOSENSORS & BIOELECTRONICS, 2013, 40 (01): : 50 - 56
12345